BDBM50572240 CHEMBL4857685

SMILES CN(C)c1ccc(\N=N\c2ccccn2)c(O)c1

InChI Key InChIKey=RBYWVGOQLYTZCK-FOCLMDBBSA-N

Data  21 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 21 hits for monomerid = 50572240   

Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50:  230nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase RIO2(Homo sapiens (Human))
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50:  130nMAssay Description:Inhibition of RIOK2 in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50:  220nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50:  210nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50:  240nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50:  260nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50:  240nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50:  260nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50:  160nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50: >500nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50:  220nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50:  160nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50:  150nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50: >500nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50: >500nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50: >500nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50:  240nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50: >500nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50: >500nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50: >500nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1,3-beta-glucan synthase component GSC2(Saccharomyces cerevisiae)
Uniformed Services University Of The Health Sciences

Curated by ChEMBL
LigandPNGBDBM50572240(CHEMBL4857685)
Affinity DataIC50:  130nMAssay Description:Inhibition of ERG in human VCaP cells after 48 hrs by Western blotting analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed